+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Botulinum Toxins in Dermatology & Cosmetology Market - Global Forecast to 2030- Product Image
Botulinum Toxins in Dermatology & Cosmetology Market - Global Forecast to 2030- Product Image
New

Botulinum Toxins in Dermatology & Cosmetology Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6081292
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Botulinum toxins have evolved from niche therapeutic agents into cornerstones of both dermatological treatment and aesthetic enhancement. Their mechanism of action-blocking neuromuscular transmission-enables clinicians to address a spectrum of conditions ranging from chronic hyperhidrosis and muscle spasticity to dynamic facial wrinkles. In recent years, advancements in formulation purity, injection techniques, and patient selection have propelled botulinum toxins beyond simple wrinkle management, integrating them into comprehensive treatment plans that improve quality of life. As demand grows, industry stakeholders must understand the drivers of adoption, emerging innovations, and regulatory shifts that shape this dynamic market. This executive summary provides an authoritative overview for decision-makers seeking actionable intelligence on the current state and future trajectory of botulinum toxin applications in dermatology and cosmetology.

Transformative Shifts in the Botulinum Toxin Landscape

The landscape of botulinum toxin usage has undergone transformative shifts driven by technological innovation, regulatory evolution, and changing patient expectations. Advanced delivery systems such as micro-dosing and blunt cannula techniques have improved precision, minimized downtime, and reduced adverse events. Reformulated toxin subtypes and novel serotypes are expanding therapeutic indications beyond aesthetic applications to neurological and autoimmune disorders, creating synergy between medical and cosmetic markets.

Regulatory agencies in key markets have updated guidelines to streamline approvals for biosimilar products, heightening competition and driving cost efficiencies. Simultaneously, consumers’ desire for natural-looking, preventative treatments is fueling interest in micro-injections among younger demographics seeking subtle enhancement. Digital consultation platforms, combined with artificial intelligence-driven imaging, are empowering clinicians to customize treatment plans and illustrate outcomes, enhancing patient engagement and satisfaction.

These shifts underscore a broader trend: the convergence of medical-grade efficacy and cosmetic appeal. As precision techniques mature and therapeutic boundaries blur, stakeholders must adapt to a marketplace where versatility and personalization are paramount.

Cumulative Impact of United States Tariffs in 2025

The implementation of revised United States tariffs in 2025 has introduced both challenges and opportunities across the botulinum toxin supply chain. Increased duties on imported bulk toxin materials have raised production costs for domestic formulators reliant on international raw materials, prompting a reevaluation of sourcing strategies. Some manufacturers have pursued vertical integration or strategic alliances with overseas suppliers to mitigate exposure, while others have accelerated development of locally produced alternatives to circumvent import levies.

Clinics and medical spas face downstream effects as acquisition costs climb, leading to tiered pricing models that differentiate between premium and value offerings. In response, providers are emphasizing package deals that combine toxin treatments with complementary procedures, distributing overhead increases across bundled services. At the same time, distributors are leveraging enhanced logistical networks to optimize inventory management and reduce lead times, partially offsetting tariff-related expenses.

Ultimately, the 2025 tariff adjustments have catalyzed supply chain resilience. Stakeholders who proactively diversified sourcing, invested in domestic manufacturing capabilities, and refined pricing strategies are positioning themselves to outpace competitors in both cost efficiency and service differentiation.

Key Insights from Market Segmentation

Diving deeper into market segmentation reveals critical insights for targeted growth strategies. Within therapeutic and aesthetic applications, hyperhidrosis treatment spans axillary, craniofacial, palmar and plantar indications, migraine management bifurcates into chronic and episodic profiles, muscle spasm interventions address blepharospasm, cervical dystonia and spasticity, while wrinkle correction encompasses bunny lines, crow’s feet, forehead creases and frown lines. Such granular differentiation enables clinicians to tailor protocols and formulate specialized service lines.

On the product front, Type A formulations dominate, with leading sub-brands offering distinct potency profiles and diffusion characteristics, while Type B solutions, represented by a focused lineup of one primary brand, cater to niche patient segments resistant to Type A. This duality encourages competitive positioning based on onset speed, duration of effect and immunogenicity.

End-user channels demonstrate further complexity. Cosmetic centers and private dermatology clinics serve as hubs for elective aesthetic procedures, whereas multispecialty and private hospitals deliver a blend of therapeutic and cosmetic services. Franchise-operated and independent medical spas are capitalizing on lifestyle wellness trends, integrating toxin treatments into broader noninvasive rejuvenation portfolios. Gender-based utilization shows that middle-aged and young adult women drive the bulk of cosmetic demand, while middle-aged and young adult men, increasingly open to preventative aesthetics, represent a growth frontier.

Age segmentation underscores that young adults aged 18-30 seek subtle preventative treatments, middle-aged clients (31-45) pursue both aesthetic refinement and therapeutic relief, and older adults (46-60) prioritize corrective procedures for established wrinkles and muscular conditions. Finally, injection technique preferences-deep plane blunt cannula approaches and precision micro-dosing-highlight the market’s shift toward minimally invasive, safety-focused practices that balance efficacy with rapid recovery.

Key Regional Insights in Botulinum Toxin Adoption

Regional dynamics shape competitive strategies and investment priorities. In the Americas, high consumer awareness and established reimbursement pathways for therapeutic uses drive robust demand, particularly in major metropolitan areas where luxury clinics leverage advanced imaging and customized protocols. Market maturity in North America coexists with rapid growth in Latin America, where rising disposable incomes and expanding medical tourism foster increased adoption.

Europe, the Middle East and Africa present a tapestry of regulatory environments and reimbursement landscapes. Western Europe’s stringent approval standards ensure high-quality products but can slow market entry, while Eastern European markets offer cost-sensitive opportunities driven by medical spa proliferation. The Middle East’s affluent clientele fuels demand for premium treatments, and in Africa, select urban centers are emerging as regional hubs for aesthetic services.

Asia-Pacific reflects unparalleled growth potential, with urban centers in Northeast Asia exhibiting advanced clinical infrastructure and regulatory frameworks that mirror Western models. Southeast Asia’s burgeoning middle class and medical tourism corridors attract international brands, while Australia and New Zealand maintain steady demand supported by high per-capita spend on cosmetic procedures.

Key Competitive Company Insights

Competitive dynamics are defined by a blend of legacy leaders and agile newcomers. Allergan, Inc. remains synonymous with pioneering formulations and extensive physician training programs, setting service standards. Daewoong Pharmaceutical advances novel formulation technologies alongside robust manufacturing capacity, while Hanwha Pharma leverages regional distribution networks to expand reach. Hugel, Inc. differentiates through speciality serotypes, targeting both aesthetic and therapeutic segments.

Ipsen Group emphasizes tailored dosing paradigms and digital engagement tools to enhance clinician-patient interactions. Lanzhou Institute of Biological Products brings to market domestically produced toxins that offer cost competitiveness in key emerging markets. Medytox combines research-intensive R&D pipelines with strategic partnerships to accelerate global expansion, whereas Merz Pharmaceuticals focuses on comprehensive portfolio diversification that spans toxins, fillers and neuromodulators. Revance Therapeutics rounds out the landscape with proprietary delivery technologies designed to optimize onset times and diffusion profiles.

Together, these companies underscore a competitive focus on formulation innovation, clinician education, and integrated service offerings as they vie for market share across therapeutic and aesthetic applications.

Actionable Recommendations for Industry Leaders

Industry leaders should adopt a multi-pronged approach to capitalize on evolving market dynamics. First, investing in advanced injection training programs that emphasize micro-dosing and blunt cannula techniques will elevate treatment safety and patient satisfaction. Second, diversifying product portfolios to include both premium and value-tier formulations can address varying consumer segments and buffer against tariff-driven cost increases.

Third, forging strategic alliances with regional partners can streamline supply chains and facilitate entry into high-growth markets in Latin America, Eastern Europe and Southeast Asia. Fourth, integrating digital consultation platforms with AI-powered imaging will enhance treatment planning and drive higher conversion rates. Fifth, expanding service models to bundle toxin treatments with complementary aesthetic or therapeutic procedures can improve revenue per patient and strengthen client retention.

By executing these actionable recommendations, organizations will not only navigate regulatory and tariff headwinds but also position themselves at the forefront of clinical innovation and consumer demand.

Conclusion on Evolving Market Dynamics

The botulinum toxin market stands at the intersection of medical necessity and aesthetic desire, shaped by regulatory shifts, technological advancements and evolving consumer preferences. The integration of precision delivery techniques, diversified product offerings and strategic regional partnerships is redefining competitive advantage. As tariffs reshape supply-chain economics, stakeholders who embrace portfolio agility and invest in clinician training will emerge as market leaders. Ultimately, success will hinge on the ability to marry scientific rigor with service excellence, delivering safe, personalized treatments that fulfill both therapeutic and cosmetic aspirations.

Market Segmentation & Coverage

This research report categorizes the Botulinum Toxins in Dermatology & Cosmetology Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Hyperhidrosis
    • Axillary
    • Craniofacial
    • Palmar
    • Plantar
  • Migraine
    • Chronic
    • Episodic
  • Muscle Spasms
    • Blepharospasm
    • Cervical Dystonia
    • Spasticity
  • Wrinkles
    • Bunny Lines
    • Crow's Feet
    • Forehead Lines
    • Frown Lines
  • Type A
    • Brands-A1
    • Brands-A2
  • Type B
    • Brands-B1
  • Clinics
    • Cosmetic Centers
    • Private Dermatology Clinics
  • Hospitals
    • Multispecialty Hospitals
    • Private Hospitals
  • Medical Spas
    • Franchise-operated Spas
    • Independent Spas
  • Female
    • Middle-Aged Women
    • Young Adult Women
  • Male
    • Middle-Aged Men
    • Young Adult Men
  • 18-30
    • Young Adults
  • 31-45
    • Middle-Aged
  • 46-60
    • Older Adults
  • Blunt Cannula Technique
    • Deep Plane Technique
  • Micro-dosing
    • Precision Micro-dosing

This research report categorizes the Botulinum Toxins in Dermatology & Cosmetology Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Botulinum Toxins in Dermatology & Cosmetology Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Allergan, Inc.
  • Daewoong Pharmaceutical Co., Ltd.
  • Hanhwa Pharma Co. Ltd
  • Hugel, Inc.
  • Ipsen Group
  • Lanzhou Institute of Biological Products Co., Ltd.
  • Medytox Inc.
  • Merz Pharmaceuticals GmbH
  • Revance Therapeutics, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Botulinum Toxins in Dermatology & Cosmetology Market, by Application
8.1. Introduction
8.2. Hyperhidrosis
8.2.1. Axillary
8.2.2. Craniofacial
8.2.3. Palmar
8.2.4. Plantar
8.3. Migraine
8.3.1. Chronic
8.3.2. Episodic
8.4. Muscle Spasms
8.4.1. Blepharospasm
8.4.2. Cervical Dystonia
8.4.3. Spasticity
8.5. Wrinkles
8.5.1. Bunny Lines
8.5.2. Crow's Feet
8.5.3. Forehead Lines
8.5.4. Frown Lines
9. Botulinum Toxins in Dermatology & Cosmetology Market, by Product Type
9.1. Introduction
9.2. Type A
9.2.1. Brands-A1
9.2.2. Brands-A2
9.3. Type B
9.3.1. Brands-B1
10. Botulinum Toxins in Dermatology & Cosmetology Market, by End-User
10.1. Introduction
10.2. Clinics
10.2.1. Cosmetic Centers
10.2.2. Private Dermatology Clinics
10.3. Hospitals
10.3.1. Multispecialty Hospitals
10.3.2. Private Hospitals
10.4. Medical Spas
10.4.1. Franchise-operated Spas
10.4.2. Independent Spas
11. Botulinum Toxins in Dermatology & Cosmetology Market, by Gender
11.1. Introduction
11.2. Female
11.2.1. Middle-Aged Women
11.2.2. Young Adult Women
11.3. Male
11.3.1. Middle-Aged Men
11.3.2. Young Adult Men
12. Botulinum Toxins in Dermatology & Cosmetology Market, by Age Group
12.1. Introduction
12.2. 18-30
12.2.1. Young Adults
12.3. 31-45
12.3.1. Middle-Aged
12.4. 46-60
12.4.1. Older Adults
13. Botulinum Toxins in Dermatology & Cosmetology Market, by Injection Technique
13.1. Introduction
13.2. Blunt Cannula Technique
13.2.1. Deep Plane Technique
13.3. Micro-dosing
13.3.1. Precision Micro-dosing
14. Americas Botulinum Toxins in Dermatology & Cosmetology Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Botulinum Toxins in Dermatology & Cosmetology Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Botulinum Toxins in Dermatology & Cosmetology Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Allergan, Inc.
17.3.2. Daewoong Pharmaceutical Co., Ltd.
17.3.3. Hanhwa Pharma Co. Ltd
17.3.4. Hugel, Inc.
17.3.5. Ipsen Group
17.3.6. Lanzhou Institute of Biological Products Co., Ltd.
17.3.7. Medytox Inc.
17.3.8. Merz Pharmaceuticals GmbH
17.3.9. Revance Therapeutics, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET MULTI-CURRENCY
FIGURE 2. BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET MULTI-LANGUAGE
FIGURE 3. BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY GENDER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY GENDER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY INJECTION TECHNIQUE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY INJECTION TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HYPERHIDROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY AXILLARY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY CRANIOFACIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PALMAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PLANTAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HYPERHIDROSIS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MIGRAINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY CHRONIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY EPISODIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MUSCLE SPASMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BLEPHAROSPASM, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY CERVICAL DYSTONIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY SPASTICITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MUSCLE SPASMS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY WRINKLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BUNNY LINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY CROW'S FEET, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY FOREHEAD LINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY FROWN LINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY WRINKLES, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY TYPE A, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BRANDS-A1, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BRANDS-A2, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY TYPE A, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY TYPE B, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BRANDS-B1, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY TYPE B, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY COSMETIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRIVATE DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MULTISPECIALTY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MEDICAL SPAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY FRANCHISE-OPERATED SPAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY INDEPENDENT SPAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MEDICAL SPAS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MIDDLE-AGED WOMEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY YOUNG ADULT WOMEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MIDDLE-AGED MEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY YOUNG ADULT MEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MALE, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 18-30, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY YOUNG ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 18-30, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 31-45, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MIDDLE-AGED, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 31-45, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 46-60, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY OLDER ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 46-60, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY INJECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BLUNT CANNULA TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY DEEP PLANE TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BLUNT CANNULA TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MICRO-DOSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRECISION MICRO-DOSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MICRO-DOSING, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HYPERHIDROSIS, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MUSCLE SPASMS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY WRINKLES, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY TYPE A, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY TYPE B, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MEDICAL SPAS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MALE, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 18-30, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 31-45, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 46-60, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY INJECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BLUNT CANNULA TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MICRO-DOSING, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HYPERHIDROSIS, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MUSCLE SPASMS, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY WRINKLES, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY TYPE A, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY TYPE B, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MEDICAL SPAS, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MALE, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 18-30, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 31-45, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 46-60, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY INJECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BLUNT CANNULA TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MICRO-DOSING, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HYPERHIDROSIS, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MUSCLE SPASMS, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY WRINKLES, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY TYPE A, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY TYPE B, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MEDICAL SPAS, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MALE, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 18-30, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 31-45, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 46-60, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY INJECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BLUNT CANNULA TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MICRO-DOSING, 2018-2030 (USD MILLION)
TABLE 142. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HYPERHIDROSIS, 2018-2030 (USD MILLION)
TABLE 144. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
TABLE 145. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MUSCLE SPASMS, 2018-2030 (USD MILLION)
TABLE 146. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY WRINKLES, 2018-2030 (USD MILLION)
TABLE 147. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY TYPE A, 2018-2030 (USD MILLION)
TABLE 149. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY TYPE B, 2018-2030 (USD MILLION)
TABLE 150. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 152. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 153. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MEDICAL SPAS, 2018-2030 (USD MILLION)
TABLE 154. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 155. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 156. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MALE, 2018-2030 (USD MILLION)
TABLE 157. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 158. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 18-30, 2018-2030 (USD MILLION)
TABLE 159. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 31-45, 2018-2030 (USD MILLION)
TABLE 160. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 46-60, 2018-2030 (USD MILLION)
TABLE 161. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY INJECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 162. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BLUNT CANNULA TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 163. CANADA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MICRO-DOSING, 2018-2030 (USD MILLION)
TABLE 164. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HYPERHIDROSIS, 2018-2030 (USD MILLION)
TABLE 166. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
TABLE 167. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MUSCLE SPASMS, 2018-2030 (USD MILLION)
TABLE 168. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY WRINKLES, 2018-2030 (USD MILLION)
TABLE 169. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY TYPE A, 2018-2030 (USD MILLION)
TABLE 171. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY TYPE B, 2018-2030 (USD MILLION)
TABLE 172. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 174. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 175. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MEDICAL SPAS, 2018-2030 (USD MILLION)
TABLE 176. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 177. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 178. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MALE, 2018-2030 (USD MILLION)
TABLE 179. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 180. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 18-30, 2018-2030 (USD MILLION)
TABLE 181. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 31-45, 2018-2030 (USD MILLION)
TABLE 182. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 46-60, 2018-2030 (USD MILLION)
TABLE 183. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY INJECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 184. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BLUNT CANNULA TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 185. MEXICO BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MICRO-DOSING, 2018-2030 (USD MILLION)
TABLE 186. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HYPERHIDROSIS, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MUSCLE SPASMS, 2018-2030 (USD MILLION)
TABLE 190. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY WRINKLES, 2018-2030 (USD MILLION)
TABLE 191. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 192. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY TYPE A, 2018-2030 (USD MILLION)
TABLE 193. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY TYPE B, 2018-2030 (USD MILLION)
TABLE 194. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 196. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 197. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MEDICAL SPAS, 2018-2030 (USD MILLION)
TABLE 198. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 199. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 200. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MALE, 2018-2030 (USD MILLION)
TABLE 201. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 202. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 18-30, 2018-2030 (USD MILLION)
TABLE 203. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 31-45, 2018-2030 (USD MILLION)
TABLE 204. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 46-60, 2018-2030 (USD MILLION)
TABLE 205. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY INJECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 206. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BLUNT CANNULA TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 207. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MICRO-DOSING, 2018-2030 (USD MILLION)
TABLE 208. UNITED STATES BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HYPERHIDROSIS, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
TABLE 212. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MUSCLE SPASMS, 2018-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY WRINKLES, 2018-2030 (USD MILLION)
TABLE 214. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY TYPE A, 2018-2030 (USD MILLION)
TABLE 216. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY TYPE B, 2018-2030 (USD MILLION)
TABLE 217. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 218. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 219. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 220. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MEDICAL SPAS, 2018-2030 (USD MILLION)
TABLE 221. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 222. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 223. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MALE, 2018-2030 (USD MILLION)
TABLE 224. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 225. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 18-30, 2018-2030 (USD MILLION)
TABLE 226. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 31-45, 2018-2030 (USD MILLION)
TABLE 227. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 46-60, 2018-2030 (USD MILLION)
TABLE 228. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY INJECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BLUNT CANNULA TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 230. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MICRO-DOSING, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HYPERHIDROSIS, 2018-2030 (USD MILLION)
TABLE 234. AUSTRALIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
TABLE 235. AUSTRALIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MUSCLE SPASMS, 2018-2030 (USD MILLION)
TABLE 236. AUSTRALIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY WRINKLES, 2018-2030 (USD MILLION)
TABLE 237. AUSTRALIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. AUSTRALIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY TYPE A, 2018-2030 (USD MILLION)
TABLE 239. AUSTRALIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY TYPE B, 2018-2030 (USD MILLION)
TABLE 240. AUSTRALIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 241. AUSTRALIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 242. AUSTRALIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 243. AUSTRALIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MEDICAL SPAS, 2018-2030 (USD MILLION)
TABLE 244. AUSTRALIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 245. AUSTRALIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 246. AUSTRALIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MALE, 2018-2030 (USD MILLION)
TABLE 247. AUSTRALIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 248. AUSTRALIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 18-30, 2018-2030 (USD MILLION)
TABLE 249. AUSTRALIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 31-45, 2018-2030 (USD MILLION)
TABLE 250. AUSTRALIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 46-60, 2018-2030 (USD MILLION)
TABLE 251. AUSTRALIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY INJECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 252. AUSTRALIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BLUNT CANNULA TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 253. AUSTRALIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MICRO-DOSING, 2018-2030 (USD MILLION)
TABLE 254. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HYPERHIDROSIS, 2018-2030 (USD MILLION)
TABLE 256. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MIGRAINE, 2018-2030 (USD MILLION)
TABLE 257. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MUSCLE SPASMS, 2018-2030 (USD MILLION)
TABLE 258. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY WRINKLES, 2018-2030 (USD MILLION)
TABLE 259. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 260. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY TYPE A, 2018-2030 (USD MILLION)
TABLE 261. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY TYPE B, 2018-2030 (USD MILLION)
TABLE 262. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 263. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 264. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 265. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MEDICAL SPAS, 2018-2030 (USD MILLION)
TABLE 266. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 267. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY FEMALE, 2018-2030 (USD MILLION)
TABLE 268. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MALE, 2018-2030 (USD MILLION)
TABLE 269. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 270. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 18-30, 2018-2030 (USD MILLION)
TABLE 271. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 31-45, 2018-2030 (USD MILLION)
TABLE 272. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY 46-60, 2018-2030 (USD MILLION)
TABLE 273. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY INJECTION TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 274. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY BLUNT CANNULA TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 275. CHINA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY MICRO-DOSING, 2018-2030 (USD MILLION)
TABLE 276. INDIA BOTULINUM TOXINS IN DERMATOLOGY & COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. INDIA BOTULINUM TOXINS IN

Companies Mentioned

  • Allergan, Inc.
  • Daewoong Pharmaceutical Co., Ltd.
  • Hanhwa Pharma Co. Ltd
  • Hugel, Inc.
  • Ipsen Group
  • Lanzhou Institute of Biological Products Co., Ltd.
  • Medytox Inc.
  • Merz Pharmaceuticals GmbH
  • Revance Therapeutics, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Botulinum Toxin in Medical Cosmetology Market - Global Forecast to 2030 - Product Image

Botulinum Toxin in Medical Cosmetology Market - Global Forecast to 2030

  • Report
  • 187 Pages
  • Global, United States Global, United States
From
Botulinum Toxin Market Report by Type, Application, End User, and Region 2024-2032 - Product Image

Botulinum Toxin Market Report by Type, Application, End User, and Region 2024-2032

  • Report
  • 144 Pages
  • Global
From
North America Botulinum Toxin Market Forecast to 2031 - Regional Analysis - by Product, Application, and End User - Product Image

North America Botulinum Toxin Market Forecast to 2031 - Regional Analysis - by Product, Application, and End User

  • Report
  • 77 Pages
  • North America
From
Botulinum Toxin - Global Strategic Business Report - Product Image

Botulinum Toxin - Global Strategic Business Report

  • Report
  • 353 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.